Biotech

All Articles

UK unveils strategies to release 18 new medical trial hubs

.In the middle of a yearslong clinical test downtrend in the U.K., a new public-private partnership ...

UPDATE: Genentech telegrams 93 layoffs in California after sharing plans to shutter cancer cells immunology study unit

.Observing the announcement of a sizable layoff shot in April and a primary restructuring effort unv...

Neurocrine's KarXT rival reaches in stage 2-- but only at reduced dose

.Neurocrine Biosciences has obtained its own hoped-for profile page in a stage 2 schizophrenia trial...

Vaderis' unusual capillary condition medication lowers nosebleeds

.Vaderis Rehabs' objective to build the first medicine aimed particularly at a particular unusual bl...

Navigator brings up $100M to create new autoimmune pipe

.Sat nav Medicines has actually equipped itself with $one hundred million in set A funds as the yout...

Duality finds cash for ADC tests as IPO wave spreads to Asia

.China's Duality Biotherapeutics has submitted (PDF) documentation for a Hong Kong IPO, finding a co...

YolTech offers China rights to genetics editing and enhancing treatment for $29M

.Four months after Chinese genetics modifying provider YolTech Therapies took its own cholesterol le...

Addex sell increases after Indivior offers up to $300M for substance

.Indivior is actually grabbing a tiny particle allosteric modulator tailored to treat element use ai...

Molecular Allies fine-tunes AML trial over 'suboptimal direct exposure'

.Molecular Companions has pinpointed "suboptimal visibility" to its own tetra-specific T-cell engage...

Despite combined market, a financial backing rebirth may be being available in Europe: PitchBook

.While the biotech assets scene in Europe has decreased relatively complying with a COVID-19 funding...